DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Abate As Industries Ltd (ABATEAS) share price today?

Abate As Industries Ltd (ABATEAS) is trading at ₹9.57 on the BSE, down 1.34% on the day. Source: DocStoX.

What is the PE ratio of Abate As Industries Ltd?

Abate As Industries Ltd has a price-to-earnings (PE) ratio of 136.7 in the Healthcare sector.

What is the market capitalisation of Abate As Industries Ltd?

Abate As Industries Ltd has a market capitalisation of approximately ₹156 crore.

Abate As Industries Ltd

ABATEAS·BSE·Healthcare

₹9.57▼ -0.13 (-1.34%)

Healthcare · Healthcare Services

A steady, established business

Day₹9.55

₹9.99

52W₹8

₹514%

Open

₹9.99

High

₹9.99

Low

₹9.55

Prev Close

₹9.70

Volume

6.2K

VWAP

₹9.74

Snapshot

Key fundamentals

Market Cap

₹156 Cr

P/E Ratio

136.71Expensive

P/B Ratio

0.88

EPS

₹0.07

Book Value

₹11.00

ROE

0.60%Weak

ROCE

0.61%Weak

Dividend Yield

0.00%

Debt / Equity

0.06Low

Face Value

₹10.00

52W High

₹50.53

52W Low

₹8.00

Sector

Healthcare

Industry

Healthcare Services

Expensive

None moatHigh uncertainty

Fair value estimate

₹10

▲ 5.4%upside

Trading at ₹10 — 5% below our estimate

BearFair valueBull

₹9₹10₹14

/100

Business quality — Watch the fundamentals

Growth 50Profitability 14Efficiency 0Valuation 49

Plain English

Our view

A steady, established business
Virtually debt-free balance sheet
Weak returns on equity (1%)

Strengths

Virtually debt-free balance sheet

Risks

Weak returns on equity (1%)
Expensive — trades at 137× earnings

How we got there

Fair value methods

Residual income

1% ROE fading to 12% over ~3 yrs, on ₹11 book

₹9

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹14

Analyst target

No analyst coverage

—

Blended fair value₹10

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet

Bear case

Weak returns on equity (1%)
Expensive — trades at 137× earnings

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

136.7Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

0.6%Weak

Above 15% is considered healthy for Indian equities

ROCE

0.6%Weak

Above 18% means capital is working hard

Debt/Eq

0.06Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹156 Cr

P/B

0.88

EPS

₹0.07

Div Yield

—

What changed

Recent changes

Promoters+4.86% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 136.7×

Growth

N/A

No history

Profitability

Modest

0.6% ROE

Financial health

Rock solid

D/E 0.06

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹59,921 Cr

Trades54

VWAP₹9.74

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

No growth history

Not enough annual history to compute CAGR.

Profile

Pros

Company is almost debt free.
Stock is trading at 0.88 times its book value
Debtor days have improved from 245 to 59.2 days.
Company's working capital requirements have reduced from 357 days to 75.1 days

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding is low: 32.4%
Tax rate seems low

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 4.86 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

32%

Promoter

Promoters

32.4%+4.86

Public

13.9%+10.04

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

53.7%

Total shareholders

3,030+450 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter32.42%

Public13.87%

Others53.71%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1991, Abate As Industries Ltd primarily operates in the eye healthcare segment through its super specialty hospitals and optical outlets[1]